Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

Abstract

A phytochemical and nutraceutical composition and method for protection against a wide spectrum of viral and bacterial infections, including Covid-19, and for treatment of established infection and infectious inflammation. The composition includes a novel combination of vitamin, mineral, nutraceutical and phytochemical supplements. The composition of supplements and method may be compounded as a pill, tablet, powder, capsule or liquid be taken orally one or more times per day. Vitamin C and vitamin E along with zinc complexed with pyrithione or citrate are used in conjunction with nutraceuticals and phytochemicals provided, respectively, as immune boosters and antiviral agents along with anti-inflammatory nutraceuticals and phytochemicals.

Claims

1. A nutraceutical composition in a capsule for preventing or mollifying viral or bacterial infection, and also for preventing or mollifying viral or bacterial tissue Inflammation, the composition comprising: an effective amount of vitamin C; an effective amount of vitamin E; an effective amount of zinc; effective amounts of wide-spectrum anti-infectious phytochemicals; and effective amounts of an anti-inflammatory nutraceutical and phytochemicals, wherein an effective amount of wide-spectrum anti-infectious phytochemicals include an effective amount of five or more of the following: extracted fulvic acid; Radix bupleuri extract; Echinacea purpura extract; sage extract; pomegranate extract; Uncaria tomentosa extract; Black Elderberry extract; or American Elderberry extract.

2. The composition of claim 1, wherein an effective amount of anti-inflammatory nutraceuticals and phytochemicals includes an effective amount of two or more of the following: Nutraceuticals Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and five or more of the following anti-inflammatory phytochemicals: Boswellia serrata extract containing 3-acetyl-11-keto-beta-boswellic acid (AKBA); Maritime pine bark extract; Uncaria tomentosa extract; Commiphora myrrha extract; Resveratrol; Curcumin extract with piperine; green tea extract; and Cannabidiol.

3. The composition of claim 1, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include: five or more of the following anti-infectious phytochemicals: fulvic acid extract; Radix bupleuri extract; Echinacea purpura, sage extract; Cats Claw extract; Black Elderberry extract or American Elderberry extract; or pomegranate extract; two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids; eicosapentanoic acid (EPA); and docosahexanoic acid (DHA); and five or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extracts; Boswellia serrata extract containing 3-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa; and maritime pine bark extract.

4. The composition of claim 3, wherein: zinc is with the cofactor of methionine.

5. The composition of claim 1, wherein: the effective amount of vitamin C is 1000 mg; and the effective amount of vitamin E is 200 mg.

6. The composition of claim 3, wherein: the effective amount of zinc is in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate, or orotate forms at 25 mg.

7. The composition of claim 3, the five or more of the following anti-infectious phytochemicals and effective amounts comprise: 1000 mg of extracted fulvic acid; 800 mg Echinacea purpura; 800 mg sage extract; 400 mg Cat's Claw extract; 200 mg Black Elderberry extract or 200 mg American Elderberry extract; 400 mg pomegranate extract; and 400 mg Radix bupleuri extract.

8. The composition of claim 7, wherein: the two or more of the following anti-inflammatory nutraceuticals comprise: 1000 mg of Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and the five or more of the following anti-inflammatory phytochemicals comprise: 400 mg Curcumin extract with piperine; 300 mg Green Tea extract; 800 mg of Boswellia serrata extract, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA); 200 mg Resveratrol; 100 mg of extract of Maritime pine bark; 400 mg Commiphora myrrha extract; and 400 mg Unicaria tomentosa extract.

9. A phytochemical and nutraceutical composition in capsule form to prevent or limit development of virally induced infections and inflammation, including Covid-19, the composition comprising: an effective amount of first and second vitamins; an effective amount of a mineral; an effective amount of nutraceuticals and phytochemicals for preventing or reducing viral and bacterial infections; and an effective amount of nutraceuticals and phytochemicals for preventing or reducing viral and bacterial inflammations; wherein said first vitamin is vitamin C and said second vitamin is vitamin E; and wherein said mineral is zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms; wherein the anti-infectious nutraceuticals for preventing or reducing viral and bacterial infections include five or more of the following: extracted fulvic acid; Echinacea purpura extract; Sage extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; Radix bupleuri extract; or pomegranate extract.

10. The composition of claim 9, wherein said nutraceuticals for preventing or reducing viral and bacterial inflammations include two or more of the following: Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Alpha-lipoic acid; and wherein said anti-inflammatory phytochemicals include five or more of the following: Curcumin extract with piperine; Green Tea extract; Boswellia serrata extract, containing its most anti-inflammatory moiety, AKBA; Resveratrol: Maritime pine bark; Commiphora myrrha extract; and cannabidiol (CBD).

11. A composition in oral tablet form comprising: an effective amount of vitamin C; an effective amount of vitamin E; an effective amount of zinc, wherein zinc is in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms or complexed with methionine; effective amounts of wide-spectrum anti-infectious phytochemicals for preventing or mollifying viral or bacterial infection; and effective amounts of an anti-inflammatory nutraceutical and phytochemicals for preventing or mollifying viral or bacterial inflammation; and enveloped by an enteric coating; wherein the wide spectrum anti-infectious phytochemicals comprise five or more of the following: fulvic acid extract; Radix bupleuri extract; echinacea extract; sage extract; Cat's Claw extract; Black Elderberry extract or American Elderberry extract, or pomegranate extract; wherein the anti-inflammatory nutraceutical comprises EPA, DHA, or a combination thereof; and wherein the anti-inflammatory phytochemicals comprise five or more of the following: Curcumin extract with piperine; Green Tea extract; Boswellia serrata extract containing 3-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Cat's Claw extract; and pine bark extract.

12. A composition in parenteral form for preventing or mollifying viral or bacterial infection, and also for preventing or mollifying viral or bacterial tissue inflammation, the composition comprising: an effective amount of vitamin C; an effective amount of vitamin E; an effective amount of zinc, wherein zinc is in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms or complexed with methionine; effective amounts of wide spectrum anti-infectious phytochemicals; and effective amounts of anti-inflammatory nutraceuticals and phytochemicals; wherein the wide-spectrum anti-infectious phytochemicals comprise five or more of the following: fulvic acid extract; Radix bupleuri extract; echinacea extract; sage extract; Cat's Claw extract; Black Elderberry extract or American Elderberry; and pomegranate extract; wherein the anti-inflammatory nutraceuticals include EPA, DHA or combination thereof; and wherein the anti-inflammatory phytochemicals include five or more of the following: curcumin extract with piperine; Green Tea extract; Boswellia serrata extract; resveratrol; Commiphora myrrha extract; Cats Claw extract; and pine bark extract.

Description

DETAILED DESCRIPTION OF THE INVENTION

(1) For the purposes of this specification, the word nutraceutical, refers to a food item, or a part of a food item, that offers medical health benefits, including prevention and/or treatment of disease. More particularly, a nutraceutical is a material that is: a. a dietary supplement containing a nutritive bioactive compound; or b. a biologically active process or process material derived from a vitamin, mineral, and herbal/organic supplements plant, fungus, and animal, or a portion thereof; where the precise composition of the biologically active process or unprocessed material may be undetermined. The word phytochemical refers to non-nutritive organic components of plants that are thought to promote human health. Unlike the traditional nutrients (protein, fat, carbohydrates, vitamins and minerals), phytochemicals are not essential for life, but have a wide range of therapeutic applications. Phytochemicals, within the parent plant, help it resist microbial attack by fungi, bacteria, and viruses.

(2) Examples of a biologically active process material may include a finely chopped, powdered, pureed, or cooked material derived from plant or animal tissue, or an extract of plant or animal tissue. These agents are useful for accelerating improved immune function; and they include extracts from various plants and mixtures thereof.

(3) A novel and unique combination of vitamin, mineral and herbal/organic supplements (phytochemicals and nutraceuticals) in one formulary forming one or more compositions and methods for the purpose of fortifying the innate (cellular) and adaptive (hormonal) components of the immune system against bacterial and viral infection, and their propagation, transmission and effects.

(4) Also included in the formulary compositions are two or more natural, herbal or other organic anti-inflammatory substances for the suppression of tissue inflammation, especially in the lungs. The formulary thereby provides multimodal nutraceutical and phytochemical protection against acquisition of infection and against deleterious effects of inflammation in the lungs. The formulary is available in both oral and parenteral forms.

(5) In one preferred embodiment, the formulary composition contains: 25 mg zinc in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate or orotate forms, or with the cofactor methionine. 1000 mg vitamin C 200 mg vitamin E Two or more of the following anti-infectious nutraceuticals: 1000 mg fulvic acid 800 mg Echinacea purpura 400 mg Sage extract (Salvia officinalis) 300 mg Cat's Claw extract (Uncaria tomentosa) 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis); and Two or more of the following anti-inflammatory nutraceuticals: 1000 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). 400 mg Curcumin, including its presence in turmeric powder 300 mg Green Tea extract polyphenols. 200 mg gum resin of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto--boswellic acid (AKBA) 200 mg Resveratrol 100 mg of Pycnogenol, extract of pine bark (Pinus maritima)

(6) Any of the listed anti-infectious nutraceuticals permutated with any of the listed anti-inflammatory and, in term, combined with the Zinc and Vitamin C or E, will confer five levels of anti-infectious protection, including white blood cell fortification and activation, virucidal-bactericidal activity, enhancement of antibody production, anti-oxidant activity and anti-inflammatory activity. The oral formulary, capsule or other, is enteric-coated to prevent breakdown by gastric acid and permit delivery of unaltered nutraceuticals to the duodenum for absorption.

EXAMPLES OF EFFECTIVE COMPOSITIONS AND METHODS OF THE INVENTION OF ONE PREFERRED EMBODIMENT

Example 1

(7) 1. A nutraceutical composition in capsule or other oral form for preventing or mollifying viral or bacterial infection, and also for preventing or mollifying viral or bacterial tissue inflammation consisting of: an effective amount of vitamin C; an effective amount of vitamin E; an effective amount of zinc; effective amounts of wide-spectrum anti-infectious phytochemicals; and effective amounts of an anti-inflammatory nutraceutical and phytochemicals.

Example 2

(8) 2. The composition of example 1, wherein an effective amount of wide-spectrum anti-infectious phytochemicals include an effective amount of five or more of the following: extracted fulvic acid; Radix bupleuri extract; Echinacea purpura extract; sage extract; pomegranate extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract.

Example 3

(9) 3. The composition of example 1, wherein an effective amount of anti-inflammatory nutraceuticals and phytochemicals include an effective amount of two or more of the following: Nutraceuticals Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and five or more of the following anti-inflammatory phytochemicals: Boswellia serrata extract containing 3-acetyl-11-keto-beta-boswllic acid (AKBA); Maritime pine bark extract (Pinus maritima); Unicaria tomentosa extract; Commiphora myrrha extract; Resveratrol; Curcumin extract with piperine; green tea extract; and Cannabidiol.

Example 4

(10) 4. The composition of example 1, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include: Five or more of the following anti-infectious phytochemicals: fulvic acid extract; Radix bupleuri extract; Echinacea purpura; sage extract; Cats Claw extract (Uncaria tomentosa); Black Elderberry extract or American Elderberry, pomegranate extract and two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Five or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extracts; extract containing 3-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa; and maritime pine bark extract

Example 5

(11) 5. The composition of example 4, wherein: zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms.

Example 6

(12) 6. The composition of example 4, wherein: zinc with the cofactor of methionine.

Example 7

(13) 7. The composition of example 1, wherein: the effective amount of vitamin C is 1000 mg; the effective amount of vitamin E is 200 mg.

Example 8

(14) 8. The composition as in example 5, wherein: effective amount of zinc in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate, orotate forms is 25 mg.

Example 9

(15) 9. The composition as in example 5, consisting of: Five or more of the following anti-infectious phytochemicals and effective amounts: 1000 mg of extracted fulvic acid; 800 mg Echinacea purpura; 800 mg sage extract (Salvia officinalis); 400 Mg Cat's Claw extract (Uncaria tomentosa); 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis); 400 mg pomegranate extract; 400 mg Radix bupleuri extract.

Example 10

(16) 10. The composition in example 9, consisting of: two or more of the following anti-inflammatory nutraceuticals and effective amounts: 1000 mg Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); 200 mg Alpha-lopoic acid; And five or more of the following anti-inflammatory phytochemicals: 400 mg Curcumin extract with piperine; 300 mg Green Tea extract; 800 mg of Boswellia serrata extract, containing its most anti-inflammatory moiety, three-acetyl-11-keto-beta-boswellic acid (AKBA); 200 mg Resveratrol; 100 mg of extract of Maritime pine bark (Pinus maritima); 400 mg Commiphora myrrha extract; and 400 mg Unicaria tomentosa extract.

Example 11

(17) 11. A method employing the composition recited in example 10, to prevent or limit development of virally induced infections and inflammation comprising the steps of: a) preparing the composition of example 10 for human consumption; b) processing composition prepared for human consumption recited in example 10 in tablet, powder, pill, capsule or liquid to be taken orally; and c) administering the processed composition recited in example 10 to a human being periodically.

Example 12

(18) 12. A method for treating a patient having symptoms caused by a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, said nutraceutical portion of the composition consisting of vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include five or more of the following anti-infectious phytochemicals: a) fulvic acid; Echinacea purpura extract; sage extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; pomegranate extract; and Radix bupleuri extract; and two or more of the following anti-inflammatory nutraceuticals: b) Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA}; and Alpha-lipoic acid; and five or more of the following anti-inflammatory phytochemicals: c) Curcumin extract with piperine; green tea extract; Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa extract; extract of maritime pine bark; green tea extract; and d) Cannabidiol (CBD).

Example 13

(19) 13. The method as in example 12, wherein, the step of adding a nutraceutical composition administering nutraceutical composition containing zinc with the cofactor of methionine.

Example 14

(20) 14. The method as in example 13, wherein the step of administering the nutraceutical composition in the effective amount of vitamin C 1000 mg; effective amount of vitamin E is 200 mg; and the effective amount of zinc is 25 mg

Example 15

(21) 15. The method as in example 14, wherein the step of administering the effective amount of anti-infectious nutraceuticals in the composition include two or more of the following anti-infectious phytochemicals: a) 1000 mg fulvic acid extract; b) 800 mg Echinacea purpura: c) 800 mg Sage extract; d) 400 mg Cat's Claw extract (Unicaria tomentsa); and e) 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis) f) 400 mg pomegranate extract; and g) 400 mg Radix bupleuri extract.

Example 16

(22) 16. The method as in example 15, wherein the step of administering the effective amount of anti-inflammatory phytochemicals and nutraceuticals include two or more of the following anti-inflammatory nutraceuticals: a) 1000 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and 200 mg Alpha-lipoic acid; and five or more of the following anti-inflammatory phytochemicals: b) 400 mg curcumin extract with piperine; c) 300 mg Green Tea extract; d) 800 mg of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA); f) 200 mg Resveratrol; 150 mg extract of Maritime pine bark extract; 400 mg Commiphora myrrha extract; and 400 mg Uncaria tomentosa extract; and 50 mg cannabidiol (CBD).

Example 17

(23) 17. A phytochemical and nutraceutical composition to prevent or limit development of virally induced infections and inflammation, including Covid-19, comprising: an effective amount of first and second vitamins; an effective amount of a mineral; an effective amount of a nutraceutical and a phytochemical compound for preventing or reducing viral and bacterial infections; and an effective amount of a nutraceutical and phytochemical compound that preventing or reducing viral and bacterial inflammations.

Example 18

(24) 18. A phytochemical/nutraceutical composition as in example 17, wherein: said first vitamin is vitamin C and said second vitamin is vitamin E; said mineral is zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms

Example 19

(25) 19. A phytochemical/nutraceutical composition as in example 18, wherein: said effective amount of a nutraceutical compound for preventing or reducing viral and bacterial infections including five or more of the following anti-infectious phytochemicals: extracted fulvic acid; Echinacea purpura extract; Sage extract; Uncaria tomentosa extract; and Black Elderberry extract or American Elderberry extract; Radix bupleuri extract; pomegranate extract;

Example 20

(26) 20. A nutraceutical composition as in example 19, wherein: said effective amount of said nutritional compound preventing or reducing viral and bacterial inflammations includes two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Alpha-lipoic acid; And five or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extract; Boswellia serrata extract, containing its most anti-inflammatory moiety, AKBA; Resveratrol: Maritime pine bark; Commiphora myrrha extract, and cannabidiol (CBD).

(27) In a preferred embodiment, the formulary composition contains: 25 mg zinc in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate or orotate forms, or with the cofactor methionine. 1000 mg vitamin C 200 mg vitamin E Five or more of the following wide-spectrum anti-infectious phytochemicals: 1000 mg extracted fulvic acid 400 mg Radix bupleuri extract 400 mg Uncaria tomentosa extract 400 mg pomegranate extract 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis); 800 mg Sage extract (Salvia officinalis) 800 mg Echinacea purpura extract and the two anti-inflammatory nutraceuticals: 1000 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). 200 mg Alpha-lipoic acid and five or more of the following anti-inflammatory phytochemicals 800 mg Boswellia serrata extract, containing its most anti-inflammatory moiety, 3-acetyl-11-keto--boswellic acid (AKBA) 150 mg Maritime pine bark extract (Pinus maritima) 400 mg Uncaria tomentosa extract 400 mg Commiphora myrrha extract 200 mg Resveratrol 400 mg Curcumin extract with piperine 300 mg Green Tea extract 50 mg Cannabidiol (CBD)

Examples of Compositions and Methods of Second Preferred Embodiment of the Invention

Example 21

(28) 21. A nutraceutical composition in capsule or other oral form for preventing or mollifying viral or bacterial infection, and also for preventing or mollifying viral or bacterial tissue inflammation consisting of: an effective amount of vitamin C; an effective amount of vitamin E; an effective amount of zinc; effective amounts of wide-spectrum anti-infectious phytochemicals; and effective amounts of an anti-inflammatory nutraceutical and phytochemicals.

Example 22

(29) 22. The composition of example 21, wherein an effective amount of wide-spectrum anti-infectious phytochemicals include an effective amount of five or more of the following: extracted fulvic acid; Radix bupleuri extract; Echinacea purpura extract; sage extract; pomegranate extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract.

Example 23

(30) 23. The composition of example 21, wherein an effective amount of anti-inflammatory nutraceuticals and phytochemicals include an effective amount of two or more of the following: Nutraceuticals Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and five or more of the following anti-inflammatory phytochemicals: Boswellia serrata extract containing 3-acetyl-11-keto-beta-boswllic acid (AKBA); Maritime pine bark extract (Pinus maritima); Unicaria tomentosa extract; Commiphora myrrha extract; Resveratrol; Curcumin extract with piperine; green tea extract; and Cannabidiol.

Example 24

(31) 24. The composition of example 21, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include: Five or more of the following anti-infectious phytochemicals: fulvic acid extract; Radix bupleuri extract; Echinacea purpura; sage extract; Cats Claw extract (Uncaria tomentosa); Black Elderberry extract or American Elderberry, pomegranate extract and two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Five or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extracts; Boswellia serata extract containing 3-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa; and maritime pine bark extract.

Example 25

(32) 25. The composition of example 24, wherein: zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms.

Example 26

(33) 26. The composition of example 24, wherein: zinc with the cofactor of methionine.

Example 27

(34) 27. The composition of example 21, wherein: the effective amount of vitamin C is 1000 mg; the effective amount of vitamin E is 200 mg.

Example 28

(35) 28. The composition as in example 25, wherein: an effective amount of zinc in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate, orotate forms is 25 mg.

Example 29

(36) 29. The composition as in example 25, consisting of: Five or more of the following anti-infectious phytochemicals and effective amounts: 1000 mg of extracted fulvic acid; 800 mg Echinacea purpura; 800 mg sage extract (Salvia officinalis); 400 Mg Cat's Claw extract (Uncaria tomentosa); 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis); 400 mg pomegranate extract; 400 mg Radix bupleuri extract.

Example 30

(37) 30. The composition in example 29, consisting of: two or more of the following anti-inflammatory nutraceuticals and effective amounts: 1000 mg Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); 200 mg Alpha-lopoic acid; And five or more of the following anti-inflammatory phytochemicals: 400 mg Curcumin extract with piperine; 300 mg Green Tea extract; 800 mg of Boswellia serrata extract, containing its most anti-inflammatory moiety, three-acetyl-11-keto-beta-boswellic acid (AKBA); 200 mg Resveratrol; 100 mg of extract of Maritime pine bark (Pinus maritima); 400 mg Commiphora myrrha extract; and 400 mg Unicaria tomentosa extract.

Example 31

(38) 31. A method employing the composition recited in example 30, to prevent or limit development of virally induced infections and inflammation comprising the steps of: a) preparing the composition of example 30 for human consumption; b) processing composition prepared for human consumption recited in example 30 in tablet, powder, pill, capsule or liquid to be taken orally; and c) administering the processed composition recited in example 30, to a human being periodically.

Example 32

(39) 32. A method for treating a patient having symptoms caused by a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, said nutraceutical portion of the composition consisting of vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include five or more of the following anti-infectious phytochemicals: e) fulvic acid; Echinacea purpura extract; sage extract; extract; Black Elderberry extract or American Elderberry extract; pomegranate extract; and Radix bupleuri extract; and two or more of the following anti-inflammatory nutraceuticals: f) Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA}; and Alpha-lipoic acid; and five or more of the following anti-inflammatory phytochemicals: g) Curcumin extract with piperine; green tea extract; Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; extract; extract of maritime pine bark; green tea extract; and h) Cannabidiol (CBD).

Example 33

(40) 33. The method as in example 32, wherein, the step of adding a nutraceutical composition administering nutraceutical composition containing zinc with the cofactor of methionine.

Example 34

(41) 34. The method as in example 33, wherein the step of administering the nutraceutical composition in the effective amount of vitamin C 1000 mg; effective amount of vitamin E is 200 mg; and the effective amount of zinc is 25 mg.

Example 35

(42) 35. The method as in example 34, wherein the step of administering the effective amount of anti-infectious nutraceuticals in the composition include two or more of the following anti-infectious phytochemicals: a) 1000 mg fulvic acid extract; b) 800 mg Echinacea purpura: c) 800 mg Sage extract; d) 400 mg Cat's Claw extract (Unicaria tomentsa); and e) 200 mg Black Elderberry extract (Sambucus nigra) or 200 mg American Elderberry extract (Sambucus canadensis) f) 400 mg pomegranate extract; and g) 400 mg Radix bupleuri extract.

Example 36

(43) 36. The method as in example 35, wherein the step of administering the effective amount of anti-inflammatory phytochemicals and nutraceuticals include two or more of the following anti-inflammatory nutraceuticals: a) 1000 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and 200 mg Alpha-lipoic acid; and five or more of the following anti-inflammatory phytochemicals: b) 400 mg curcumin extract with piperine; c) 300 mg Green Tea extract; d) 800 mg of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA); f) 200 mg Resveratrol; 150 mg extract of Maritime pine bark extract; 400 mg Commiphora myrrha extract; and 400 mg Uncaria tomentosa extract; and 50 mg cannabidiol (CBD).

Example 37

(44) 37. A phytochemical and nutraceutical composition to prevent or limit development of virally induced infections and inflammation, including Covid-19, comprising: an effective amount of first and second vitamins; an effective amount of a mineral; an effective amount of a nutraceutical and a phytochemical compound for preventing or reducing viral and bacterial infections; and an effective amount of a nutraceutical and phytochemical compound that preventing or reducing viral and bacterial inflammations.

Example 38

(45) 38. A phytochemical/nutraceutical composition as in example 37, wherein: said first vitamin is vitamin C and said second vitamin is vitamin E; said mineral is zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms.

Example 39

(46) 39. A phytochemical/nutraceutical composition as in example 38, wherein: said effective amount of a nutraceutical compound for preventing or reducing viral and bacterial infections including five or more of the following anti-infectious phytochemicals: extracted fulvic acid; Echinacea purpura extract; Sage extract; Uncaria tomentosa extract; and Black Elderberry extract or American Elderberry extract; Radix bupleuri extract; pomegranate extract; Example 40 40. A nutraceutical composition as in example 39, wherein: said effective amount of said nutritional compound preventing or reducing viral and bacterial inflammations includes two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Alpha-lipoic acid; And five or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extract; Boswellia serrata extract, containing its most anti-inflammatory moiety, AKBA; Resveratrol: Maritime pine bark; Commiphora myrrha extract, and Cannabidiol (CBD).

(47) Any of the listed wide-spectrum anti-infectious nutraceuticals and phytochemicals permutated with any of the listed anti-inflammatory nutraceuticals and phytochemicals will confer five levels of anti-infectious protection, including white blood cell fortification and activation, virucidal-bactericidal activity, enhancement of antibody production, anti-oxidant activity and anti-inflammatory activity. The oral formulary, capsule or other, is enteric-coated to prevent breakdown by gastric acid and permit delivery of unaltered nutraceuticals and phytochemicals to the duodenum for absorption.

(48) The method of the invention includes the steps of providing a patient with an antiviral and/or anti-inflammatory capsule or other oral form containing a nutraceutical and phytochemical composition described herein to treat viral infections and inflammations resulting therefrom, once or more daily, in prescribed amounts, depending on the condition of the patient.

(49) Although the present invention has been described in detail with particular reference in a preferred embodiment thereof, it should be understood that the invention is capable of other different embodiments, and its details are capable of modifications in various obvious respects. As is readily apparent to those skilled in the art, variations and modifications can be affected while remaining within the spirit and scope of the invention. Accordingly, the foregoing disclosure description is for illustrative purposes only and do not any way limit the invention which is defined only by the claims.